Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-24-020876

EVP Research & Development sold 7,300 shares at $57.02 ($416,246)

  • EVP Research & Development acquired 5,300 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Malik Fady Ibraham · EVP Research & Development

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-07-23 Sale : show line 1 in the form 10b5-1 −2,000 $57.02 $114,040 129,004 D
2024-07-23 Exercise or conversion : show line 2 in the form 10b5-1 +5,300 $7.96 $42,188 134,304 D
2024-07-23 Sale : show line 3 in the form 10b5-1 −5,300 $57.02 $302,206 129,004 D
Open-market sales · 7,300 sh · avg $57.02 · $416,246

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-07-23 Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) −5,300 53,000 D
Loading xslF345X05/form4.xml…